Format

Send to

Choose Destination
Annu Rev Med. 1992;43:269-82.

Osteogenesis imperfecta.

Author information

1
Department of Pathology, University of Washington, Seattle 98195.

Abstract

Recent biochemical, linkage, and molecular genetic studies have demonstrated that, in almost every instance, osteogenesis imperfecta results from mutations in the genes that encode the chains of type I collagen. Such studies have done much to improve our understanding of the molecular basis of brittle bone disease, and have provided significant inroads into molecular diagnosis and prognostic counseling. Nonetheless, further investigation is needed urgently to identify forms of medical therapy that will decrease morbidity in osteogenesis imperfecta.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center